Statement of Organization, Functions, and Delegations of Authority, 47189-47190 [2011-19739]
Download as PDF
<![CDATA[
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 150 / Thursday, August 4, 2011 / Notices
although legal staff likely will be
involved in preparing the actual
submission to the Commission, and has
applied an average hourly wage of $100/
hour for their combined labor.
Accordingly, staffs best estimate for the
total labor costs for up to 15 information
requests is $210,000 per year, for a total
of $630,000 over the entire three-year
period. Staff believes that the capital or
other non-labor costs associated with
the information requests are minimal.
Although the information requests may
necessitate that industry members
maintain the requested information
provided to the Commission, they
should already have in place the means
to compile and maintain business
records.
Request for comment: You can file a
comment online or on paper. For the
Commission to consider your comment,
we must receive it on or before October
3, 2011. Write ‘‘Tobacco Reports:
Paperwork Comment, FTC File No.
P054507’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission Web site, at https://
www.ftc.gov/os/publiccomments.shtm.
As a matter of discretion, the
Commission tries to remove individuals’
home contact information from
comments before placing them on the
Commission Web site. Because your
comment will be made public, you are
solely responsible for making sure that
your comment does not include any
sensitive personal information, such as
anyone’s Social Security number, date
of birth, driver’s license number or other
state identification number or foreign
country equivalent, passport number,
financial account number, or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, don’t include any ‘‘[t]rade
secret or any commercial or financial
information which is obtained from any
person and which is privileged or
confidential * * *,’’ as provided in
Section 6(f) of the FTC Act, 15 U.S.C.
46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). In particular, don’t include
competitively sensitive information,
such as costs, sales statistics,
inventories, formulas, patterns, devices,
manufacturing processes, or customer
names.
If you want the Commission to give
your comment confidential treatment,
you must file it in paper form, with a
request for confidential treatment, and
VerDate Mar<15>2010
17:29 Aug 03, 2011
Jkt 223001
you have to follow the procedure
explained in FTC Rule 4.9(c), 16 CFR
4.9(c).2 Your comment will be kept
confidential only if the FTC General
Counsel, in his or her sole discretion,
grants your request in accordance with
the law and the public interest.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online, or to send them to the
Commission by courier or overnight
service. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
tobaccoreportspra, by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that Web
site.
If you file your comment on paper,
write ‘‘Tobacco reports: Paperwork
Comment, FTC File No. P054507’’ on
your comment and on the envelope, and
mail or deliver it to the following
address: Federal Trade Commission,
Office of the Secretary, Room H–113
(Annex J), 600 Pennsylvania Avenue,
NW., Washington, DC 20580. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Visit the Commission Web site at
https://www.ftc.gov to read this Notice
and the news release describing it. The
FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before October 3, 2011. You can find
more information, including routine
uses permitted by the Privacy Act, in
the Commission’s privacy policy, at
https://www.ftc.gov/ftc/privacy.htm.
David C. Shonka,
Acting General Counsel.
[FR Doc. 2011–19672 Filed 8–3–11; 8:45 am]
BILLING CODE 6750–01–M
2 In particular, the written request for confidential
treatment that accompanies the comment must
include the factual and legal basis for the request,
and must identify the specific portions of the
comment to be withheld from the public record. See
FTC Rule 4.9(c), 16 CFR4.9(c).
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
47189
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 34075, dated
June 10, 2011) is amended to reflect the
establishment of the Office of Minority
Health and Health Equity (CAW), Office
of the Director (CA), Centers for Disease
Control and Prevention (C). This will
align this office as a direct report to the
Director, Centers for Disease Control
and Prevention (CDC), pursuant to
passage of the Patient Protection and
Affordable Care Act (Pub. L. 111–148).
I. Section C–B, Organization and
Functions, is hereby amended as
follows:
Under Part C, Centers for Disease
Control and Prevention (C), Office of the
Director (CA), add the following
organizational unit after the Office of
Diversity Management and Equal
Employment Opportunity (CAV):
Office of Minority Health and Health
Equity (CAW): The mission of the Office
of Minority Health and Health Equity
(OMHHE) is to accelerate CDC’s health
impact in the U.S population and to
eliminate health disparities for
vulnerable populations as defined by
race/ethnicity, socio-economic status,
geography, gender, age, disability status,
risk status related to sex and gender,
and among other populations that are
identified as at-risk for health
disparities. As the Office of the
Director’s organizational focus for
eliminating health disparities, OMHHE:
(1) Provides leadership for CDC-wide
policies, strategies, action planning,
implementation and evaluation to
eliminate health disparities; (2)
coordinates CDC’s response to
Presidential Executive Orders,
Congressional mandates, Secretarial and
HHS/ASH/OPHS Initiatives, and
provides timely performance reports on
minority health and health equity as
required; (3) monitors and reports on
the health status of vulnerable
populations and the effectiveness of
health protection programs; (4)
evaluates the impact of policies and
programs to achieve health disparities
elimination; (5) supports internal/
E:\FR\FM\04AUN1.SGM
04AUN1
47190
Federal Register / Vol. 76, No. 150 / Thursday, August 4, 2011 / Notices
external partnerships to advance the
science, practice and workforce for
eliminating health disparities inside/
outside CDC; (6) maintains critical
linkages with federal partners including
the Office of the Secretary, Department
of Health and Human Services, and
represents CDC on related scientific and
policy committees; (7) establishes
external advisory capacity and internal
advisory and action capacity; (8)
improves support of efforts to improve
minority health and achieve health
equity in the U.S. by collaborating with
CDC’s National Centers and other
entities; (9) synthesizes, disseminates,
and encourages use of scientific
evidence regarding effective
interventions to achieve health
disparities elimination outcomes; (10)
analyzes trends in and determinants of
health disparities to provide decision
support to CDC’s Executive Leadership
in allocating CDC resources to agencywide programs for surveillance,
research, intervention and evaluation;
(11) positions CDC to address relevant
provisions in the 2010 Patient
Protection and Affordable Care Act that
address health disparities; (12)
strengthens CDC’s global health work to
achieve equity; (13) supports CDC’s
response to public health emergencies
in vulnerable populations; and (14)
ensures administrative effectiveness and
efficiency of agency-wide efforts to
achieve health equity.
II. Delegation of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
Authority: 44 U.S.C. 3101.
Dated: July 27, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–19739 Filed 8–3–11; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSK5SPTVN1PROD with NOTICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Report of Modified
or Altered System
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services (HHS).
ACTION: Notice of Modified or Altered
System of Records (SOR).
AGENCY:
VerDate Mar<15>2010
17:29 Aug 03, 2011
Jkt 223001
In accordance with the
requirements of the Privacy Act of 1974,
we are proposing to modify or alter a
SOR titled, ‘‘Medicare Advantage
Prescription Drug (MARx) System, No.
09–70–4001,’’ last modified at 70 FR
60530 (October 18, 2005). CMS proposes
to broaden the data collected and stored
by this system as part of a redesign and
modernization of the MARx System. On
December 8, 2003, Congress passed the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173). MMA
amended the Social Security Act (the
Act) by adding the Medicare Part D
Program under Title XVIII and
mandated that CMS establish a
voluntary Medicare prescription drug
benefit program effective January 1,
2006. Under the Medicare Part D
benefit, the Act allows Medicare
payment to plans that contract with
CMS to provide qualified Part D
prescription drug coverage as described
in 42 Code of Federal Regulations (CFR)
423.401. The MARx System processes
all enrollment/disenrollment
transactions associated with the Part D
program.
The modified MARx System will
accept and store Health Plan-supplied
beneficiary residence addresses on an
initial Part C and/or Part D enrollment
or a subsequent record update
transaction from the Plan. The main
source of beneficiary residence address
is the Social Security Administration
(SSA). The address SSA provides,
however, may not be the beneficiary’s
residence address. Beneficiary addresses
are initially provided by SSA from the
beneficiary’s enrollment in Part A and/
or Part B, and frequently reflect an
address of a representative payee or a
Post Office (P.O.) Box, not the residence
of the beneficiary. This limits the
effectiveness of geographically-sensitive
Plan payment decisions. Plans have
more accurate beneficiary address
information, which is updated on a
case-by-case basis. CMS wishes to allow
this data to be transmitted in initial
enrollment and subsequent record
update transactions from the Plans, and
additionally translated into valid
residence address State and County
Codes for subsequent use in service area
determination. Support for Plansupplied residence address will
improve the accurate application of
geographically sensitive rates in Plan
payment calculation. The Plan-supplied
beneficiary residence address will be
updated and saved with the
beneficiary’s enrollment data in the
MARx System. The residence address
provided by the Plan will only apply to
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
periods when the beneficiary is enrolled
in that Plan.
We propose to modify existing routine
use number 1 that permits disclosure to
agency contractors and consultants to
include disclosure to CMS grantees who
perform a task for the agency. CMS
grantees, charges with completing
projects or activities that require CMS
data to carry out that activity, are
classified separate from CMS
contractors and/or consultants. The
modified routine use will remain as
routine use number 1. We will delete
routine use number 7 authorizing
disclosure to support constituent
requests made to a congressional
representative. If an authorization for
the disclosure has been obtained from
the data subject, then no routine use is
needed.
We will broaden the scope of
published routine uses number 8 and 9,
authorizing disclosures to combat fraud
and abuse in the Medicare and
Medicaid programs to include
combating ‘‘waste’’ which refers to
specific beneficiary/recipient practices
that result in unnecessary cost to all
Federally-funded health benefit
programs. We will add a new routine
use authorizing disclosure of
individually identifiable information to
assist in efforts to respond to a
suspected or confirmed breach of the
security or confidentiality of
information maintained in these
systems of records.
We are modifying the language in the
remaining routine uses to provide a
proper explanation as to the need for the
routine use and to provide clarity to
CMS’s intention to disclose individualspecific information contained in this
system. The routine uses will then be
prioritized and reordered according to
their usage. We will also take the
opportunity to update language in the
administrative sections to correspond
with language used in other CMS SORs.
We propose to assign a new CMS
identification number to this system to
simplify the obsolete and confusing
numbering system originally designed
to identify the Bureau, Office, or Center
that maintained information in the
Health Care Financing Administration
systems of records. The new assigned
identifying number for this system
should read: System No. 09–70–0588.
The primary purpose of the SOR is to
maintain a master file of Medicare
Advantage (MA) and Medicare
Advantage Prescription Drug (MA–PD)
plan members for accounting and
payment control; expedite the exchange
of data with MA and MA–PD; control
the posting of pro-rata amounts to the
Part B deductible of currently enrolled
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 76, Number 150 (Thursday, August 4, 2011)]
[Notices]
[Pages 47189-47190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19739]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 76 FR 34075, dated June 10, 2011) is amended
to reflect the establishment of the Office of Minority Health and
Health Equity (CAW), Office of the Director (CA), Centers for Disease
Control and Prevention (C). This will align this office as a direct
report to the Director, Centers for Disease Control and Prevention
(CDC), pursuant to passage of the Patient Protection and Affordable
Care Act (Pub. L. 111-148).
I. Section C-B, Organization and Functions, is hereby amended as
follows:
Under Part C, Centers for Disease Control and Prevention (C),
Office of the Director (CA), add the following organizational unit
after the Office of Diversity Management and Equal Employment
Opportunity (CAV):
Office of Minority Health and Health Equity (CAW): The mission of
the Office of Minority Health and Health Equity (OMHHE) is to
accelerate CDC's health impact in the U.S population and to eliminate
health disparities for vulnerable populations as defined by race/
ethnicity, socio-economic status, geography, gender, age, disability
status, risk status related to sex and gender, and among other
populations that are identified as at-risk for health disparities. As
the Office of the Director's organizational focus for eliminating
health disparities, OMHHE: (1) Provides leadership for CDC-wide
policies, strategies, action planning, implementation and evaluation to
eliminate health disparities; (2) coordinates CDC's response to
Presidential Executive Orders, Congressional mandates, Secretarial and
HHS/ASH/OPHS Initiatives, and provides timely performance reports on
minority health and health equity as required; (3) monitors and reports
on the health status of vulnerable populations and the effectiveness of
health protection programs; (4) evaluates the impact of policies and
programs to achieve health disparities elimination; (5) supports
internal/
[[Page 47190]]
external partnerships to advance the science, practice and workforce
for eliminating health disparities inside/outside CDC; (6) maintains
critical linkages with federal partners including the Office of the
Secretary, Department of Health and Human Services, and represents CDC
on related scientific and policy committees; (7) establishes external
advisory capacity and internal advisory and action capacity; (8)
improves support of efforts to improve minority health and achieve
health equity in the U.S. by collaborating with CDC's National Centers
and other entities; (9) synthesizes, disseminates, and encourages use
of scientific evidence regarding effective interventions to achieve
health disparities elimination outcomes; (10) analyzes trends in and
determinants of health disparities to provide decision support to CDC's
Executive Leadership in allocating CDC resources to agency-wide
programs for surveillance, research, intervention and evaluation; (11)
positions CDC to address relevant provisions in the 2010 Patient
Protection and Affordable Care Act that address health disparities;
(12) strengthens CDC's global health work to achieve equity; (13)
supports CDC's response to public health emergencies in vulnerable
populations; and (14) ensures administrative effectiveness and
efficiency of agency-wide efforts to achieve health equity.
II. Delegation of Authority: All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegation, provided they are consistent with this reorganization.
Authority: 44 U.S.C. 3101.
Dated: July 27, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-19739 Filed 8-3-11; 8:45 am]
BILLING CODE 4160-18-M
